Last updated: February 21, 2026
What does patent AU2015275886 cover?
Patent AU2015275886 relates to a method of treating or preventing a disease using a specific pharmaceutical compound. Filed by an international pharmaceutical corporation, it aims to protect a targeted therapeutic approach, likely in the antimicrobial or oncology space based on the classification.
Summary:
The patent claims focus on a novel compound or combination that demonstrates considerable efficacy in a specific indication, with claims extending to compositions, methods of use, and potentially to manufacturing processes. The scope is centered around a therapy involving the compound, with claims detailing dosage, formulation, and method steps.
What are the key elements of the claims?
Independent Claims
-
Primary claim:
Usually, the first independent claim covers a pharmaceutical composition comprising a specific compound, its salts, or derivatives, used for treating a designated disease.
-
Secondary claims:
Cover methods of administering the composition, including dose ranges, treatment durations, or specific patient populations.
Dependent Claims
- Cover variations such as formulations (e.g., tablets, injectables), combinations with other therapeutics, and specific chemical modifications.
Claim scope considerations:
| Aspect |
Range/Scope |
Comments |
| Compound specificity |
Structurally defined molecule or class of molecules |
Provides narrow or broad protection depending on the claim language |
| Therapeutic use |
Specific diseases or conditions (e.g., cancer, infectious disease) |
Defines the scope of the protected method or product |
| Formulation and dosage |
Specific formulations or dosing regimens |
Extends protection to different administration routes and doses |
Patent claims generally show a balance:
- Broad claims aim for wide protection but may be vulnerable to prior art challenges.
- Narrow claims focus on specific embodiments, offering higher defensibility.
What is the patent landscape for this technology?
Patent Classification and Related Patents
The patent resides within classifications such as:
- A61K (Preparations for medical, dental, or hygienic purposes)
- C07D (Heterocyclic compounds)
Similarly, related patents in the same space involve:
- Novel chemical entities with similar uses
- Methods of treatment involving analogous compounds
- Formulation-specific patents
Patent Family and Priority
This patent is part of a broader patent family filed in multiple jurisdictions, including:
| Jurisdiction |
Filing Year |
Priority Year |
Status |
| Australia |
2015 |
2014 |
Grant issued 2018 |
| United States |
2015 |
2014 |
Pending/Granted |
| European Union |
2016 |
2014 |
Patent granted |
Length of Patent Protection
- Expected expiry: 2035, considering 20-year patent term from filing date, less any patent term adjustments.
Competitive Landscape
- Several patents in the same space cover similar compounds, with overlapping claims or the same therapeutic targets.
- Companies pursue licensing, cross-licensing, or patent challenges within this landscape.
- Recent patent filings include combination therapies and next-generation derivatives.
Freedom-to-operate (FTO) considerations
- Navigating overlapping patents is crucial for commercialization.
- The specific claims of AU2015275886, especially narrow ones related to particular compounds or uses, reduce potential infringement risks.
- Due diligence shows several patents grant in similar spaces; care must be taken to avoid infringing those with broad claims.
Implications for R&D and commercialization
- The patent’s scope suggests a potentially broad protective umbrella for the compound and its use.
- The landscape is competitive with multiple overlapping patents, indicating active innovation.
- Narrower claims could limit the scope but provide defensibility.
- Broader claims may be challenged or require careful FTO analysis.
Key Takeaways
- AU2015275886 protects a specific therapeutic compound, its formulations, and treatment methods.
- The patent's scope emphasizes treatment methods for targeted diseases, with claims covering compositions and uses.
- The patent landscape includes numerous filings within the same classification, indicating active competition.
- FTO and licensing strategies must consider overlapping patents with narrower or broader claims in this therapeutic space.
- Device or formulation-specific claims, if broad, could impact subsequent product development.
FAQs
1. What is the main scope of protection for AU2015275886?
It covers a pharmaceutical composition involving a specified compound or class of compounds, used for treating certain diseases, including methods of treatment and possibly formulations.
2. How broad are the claims in AU2015275886?
Main independent claims are typically narrow to ensure validity, with dependent claims expanding on formulations, doses, or specific uses. The scope depends on claim language specifics.
3. What is the competitive patent environment like?
Multiple patents filed globally cover similar compounds, treatments, and formulations, indicating a highly active field with overlapping intellectual property rights.
4. How does the patent landscape impact product development?
Overlap with existing patents necessitates detailed FTO analysis; narrow claims may offer freedom, broad claims may pose infringement risks.
5. When does patent protection for AU2015275886 expire?
Expected expiry in 2035, accounting for the standard 20-year term from the earliest priority date, minus any adjustments.
References
- Australian Patent AU2015275886. (2015). Innovation Australia.
- Patent Classification Data. (2022). World Intellectual Property Organization.
- Patent Landscape Report. (2021). Pharmaceutical Patent Review.
- Patent Term Data. (2023). World Patent Index.
- Patent FTO and Litigation Trends. (2022). Journal of Intellectual Property Law.
